William Garvin, Shareholder in FDA & Biotechnology, and Niraj Rath, Associate in Tax, authored "Regulatory Update on Acrylamide - State, Federal and International Oversight," which was published in the Food and Drug Law Institute's September/October 2017 edition of Update.